COLESTID TABLETS 1 G
COLESTIPOL HYDROCHLORIDE : 1 G · DIN 02132680 · PFIZER CANADA ULC
Health Canada status: MARKETED
What is COLESTID TABLETS?
COLESTID TABLETS 1 G contains COLESTIPOL HYDROCHLORIDE : 1 G. It is listed in the Health Canada Drug Product Database under DIN 02132680, held by PFIZER CANADA ULC, supplied as TABLET for ORAL administration. Health Canada currently lists it as marketed, status dated 18-Jul-2006. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is COLESTID TABLETS used for?
COLESTID Granules, COLESTID ORANGE Granules and COLESTID Tablets (colestipol hydrochloride) are indicated as adjunctive therapy to diet and exercise for the reduction of elevated serum cholesterol in patients with primary hypercholesterolemia (elevated low density lipoproteins). Such a reduction of serum cholesterol may reduce the risks of atherosclerotic coronary artery disease and myocardial infarction.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
Product details and regulatory record
| DIN | 02132680 |
|---|---|
| Brand name | COLESTID TABLETS |
| Generic / active ingredient | COLESTIPOL HYDROCHLORIDE : 1 G |
| Manufacturer | PFIZER CANADA ULC |
| Strength | 1 G |
| Dosage form | TABLET |
| Route of administration | ORAL |
| Schedule | Prescription |
| ATC code | C10AC02 COLESTIPOL |
| AHFS class | 24:06.04 |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 18-Jul-2006 |
| Original market date | 1995-12-31 00:00:00 |
How is it stored and handled?
Controlled room temperature (15 ° - 30 ° C). Protect from heat, direct sunlight, moisture and humidity.
How is it supplied?
COLESTID Granules are available in cartons of 30 foil packets.
What can be used instead?
Other Canadian products sharing ATC code C10AC02 COLESTIPOL. 1 of 3 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| COLESTID GRANULES | 5 G | GRANULES | PFIZER CANADA ULC | CANCELLED POST MARKET | DIN 00642975 |
| COLESTID ORANGE GRANULES | 5 G | GRANULES | PFIZER CANADA ULC | CANCELLED POST MARKET | DIN 02132699 |
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.